# Kogenate FS Regulatory Post-Marketing Surveillance

> **NCT01386268** · — · COMPLETED · sponsor: **Bayer** · enrollment: 64 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** Recombinant Factor VIII (Kogenate FS, BAY14-2222)

## Key facts

- **NCT ID:** NCT01386268
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-08
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386268, "Kogenate FS Regulatory Post-Marketing Surveillance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01386268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*